| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/13/2005 | CA2539043A1 Compositions capable of facilitating penetration across a biological barrier |
| 10/12/2005 | EP1584925A1 Novel screening method |
| 10/12/2005 | EP1584689A1 Vectors for gene mutagenesis and gene discovery |
| 10/12/2005 | EP1584686A1 Progenitor cell preservation factors and related methods and products |
| 10/12/2005 | EP1584685A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 10/12/2005 | EP1584684A1 Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene |
| 10/12/2005 | EP1584683A1 Human orphan g protein-coupled receptors |
| 10/12/2005 | EP1584678A1 Method of inducing homologous recombination of somatic cell |
| 10/12/2005 | EP1584630A1 Method for preparing a modified protein outside a host cell |
| 10/12/2005 | EP1584629A1 An in vitro method for the diagnosis of neoplastic diseases by methylation analysis of the CDH4 gene, oligonucleotides and kits useful in such method |
| 10/12/2005 | EP1584628A2 Viral protein |
| 10/12/2005 | EP1584627A1 Dimerized peptide |
| 10/12/2005 | EP1584624A1 A full-length polynucleotide coding chicken type ii collagen and the use of it |
| 10/12/2005 | EP1584232A1 Sigma receptor-deficient, mutant, non-human mammals and applications thereof |
| 10/12/2005 | EP1583966A2 Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061,17662,1468,12282, 6350, 9035,1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123,12788,17729, 65552,1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32 |
| 10/12/2005 | EP1583961A1 A novel assay to screen for anti-malarials |
| 10/12/2005 | EP1583947A2 41 human secreted proteins |
| 10/12/2005 | EP1583833A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof |
| 10/12/2005 | EP1583827A2 Crystals and structures of spleen tyrosine kinase sykkd |
| 10/12/2005 | EP1583824A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 10/12/2005 | EP1583821A2 Methods and compositions for treating urological disorders using 44390, 54181, 211, 5687, 884, 1405, 636, 4421, 5410, 30905, 2045, 16405, 18560, 2047, 33751, 52872, 14063, 20739, 32544, 43239, 44373, 51164, 53010, 16852, 1587, 2207, 22245, 2387, 52908, 69112, 14990, 18547, 115, 579, 15985, 15625, 76 |
| 10/12/2005 | EP1583820A2 Polynucleotides and polypeptides associated with the nf-kb pathway |
| 10/12/2005 | EP1583817A2 Active variants of fgf with improved specificity |
| 10/12/2005 | EP1583776A2 Protein crystal |
| 10/12/2005 | EP1583775A2 Peptide compound containing boron |
| 10/12/2005 | EP1583774A2 Methods for preventing and treating alzheimer's disease (ad) |
| 10/12/2005 | EP1583773A1 Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 10/12/2005 | EP1583772A2 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 10/12/2005 | EP1583771A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 10/12/2005 | EP1583769A2 Enhanced variants of erythropoietin and methods of use |
| 10/12/2005 | EP1583587A2 Organic compounds with biological action as thrombin inhibitors and use therof |
| 10/12/2005 | EP1583564A2 Improved linkers for pharmaceutical compounds |
| 10/12/2005 | EP1583557A2 Vaccine compositions and methods |
| 10/12/2005 | EP1583549A2 Peptide yy analogs |
| 10/12/2005 | EP1583548A2 Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
| 10/12/2005 | EP1583517A2 Methods and products for treating staphylococcal infections |
| 10/12/2005 | EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 10/12/2005 | EP1583500A2 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines |
| 10/12/2005 | EP1511765A4 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 10/12/2005 | EP1499748A4 Hepatitis c virus assay systems |
| 10/12/2005 | EP1468012A4 Biomolecule transduction motif mph-1-btm and the use thereof |
| 10/12/2005 | EP1427829A4 Multivalent protein conjugate with multiple ligand-binding domains of receptors |
| 10/12/2005 | EP1417237A4 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 10/12/2005 | EP1339867A4 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 10/12/2005 | EP1274721B1 Haemostatically active preparation containing vwf and method for the production thereof |
| 10/12/2005 | EP1259814B1 Bcmp-7 as marker for diagnosis of breast cancer |
| 10/12/2005 | EP1002866B1 TEMPERATURE SENSITIVE dtsR GENES |
| 10/12/2005 | EP0904094B1 Treatment of bone disorders with adrenomedullin |
| 10/12/2005 | EP0793723B1 New staphylokinase derivatives |
| 10/12/2005 | EP0669979B1 C-c ckr-1, c-c chemokine receptor |
| 10/12/2005 | EP0556345B2 Retroviral vectors useful for gene therapy |
| 10/12/2005 | CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 10/12/2005 | CN1681931A Use of specific Myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 10/12/2005 | CN1681930A Polypeptide having signal sequence containing FIVSI motif and oligonucleotide encoding said motif |
| 10/12/2005 | CN1681927A Improved transporters and their uses |
| 10/12/2005 | CN1681924A In vitro peptide expression library |
| 10/12/2005 | CN1681919A Chicken astrovirus type 2 |
| 10/12/2005 | CN1681846A Process for producing hydroxyalkyl starch derivatives |
| 10/12/2005 | CN1681844A Hasylated polypeptides, especially hasylated erythropoietin |
| 10/12/2005 | CN1681842A Live antenuated parasite vaccine |
| 10/12/2005 | CN1681841A Process for production of cephalosporin C |
| 10/12/2005 | CN1681840A Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 10/12/2005 | CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist |
| 10/12/2005 | CN1681836A Targeting proteins to deliver therapeutic or diagnostic reagents |
| 10/12/2005 | CN1681835A Gene families associated with stomach cancer |
| 10/12/2005 | CN1681834A Gene families associated with liver cancer |
| 10/12/2005 | CN1681530A IHNV G protein for immune stimulation |
| 10/12/2005 | CN1681518A Combination therapies with L-FMAU for the treatment of hepatitis b virus infection |
| 10/12/2005 | CN1680603A ANGPTL4/FIAF as marker for PPAR delta modulation |
| 10/12/2005 | CN1680557A Penicillium marneffei CRG5 gene, its coding protein and use |
| 10/12/2005 | CN1680555A Penicillium marneffei 60S ribosomal protein L33-B, its coding sequence and use |
| 10/12/2005 | CN1680554A Penicillium marneffei thymus resistant glubolin, its coding sequence and use |
| 10/12/2005 | CN1680553A Penicillium marneffei 40S ribosomal protein S28, its coding sequence and use |
| 10/12/2005 | CN1680458A Activated macrogol of modified protein and preparation thereof |
| 10/12/2005 | CN1680451A Immune responses against HPV antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 10/12/2005 | CN1680449A Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol |
| 10/12/2005 | CN1680448A Macrogol-interferon, preparation and use thereof |
| 10/12/2005 | CN1680443A Recombinat protein containing albumin multimer |
| 10/12/2005 | CN1680442A Truncated VEGF-related proteins |
| 10/12/2005 | CN1680440A Batyl active peptide, preparation and therepic use thereof |
| 10/12/2005 | CN1680439A Tumor transfer related protein and coding gene thereof |
| 10/12/2005 | CN1680438A Human pifl gene, its coding protein and use thereof |
| 10/12/2005 | CN1680437A Fe(II) transfer protein of crabapple and its coding gene and use |
| 10/12/2005 | CN1680436A DREB transcription factor and its coding gene and use |
| 10/12/2005 | CN1680435A Rapid separating purification of R-phycoerythrin |
| 10/12/2005 | CN1680434A Streptococcus pneumoniae antigens |
| 10/12/2005 | CN1680433A Recombinant N protein antigen and purification for transmissible gastroenteritis of swine |
| 10/12/2005 | CN1680432A Viral protein |
| 10/12/2005 | CN1680431A Crystal of human avidin protein and preparation thereof |
| 10/12/2005 | CN1680357A Extraction of soya isoflavone, concentrated soya protein and soya oligose |
| 10/12/2005 | CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist |
| 10/12/2005 | CN1679915A Peptide antagonists of zonulin and methods for use of the same |
| 10/12/2005 | CN1679638A Preparation and use of antioxidant component from protein liquid of living scorpion |
| 10/12/2005 | CN1222620C Novel promoters and gene expression method by using same |
| 10/12/2005 | CN1222618C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 10/12/2005 | CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies |
| 10/12/2005 | CN1222616C Novel human protein with cancer-inhibiting function and coding sequence thereof |
| 10/12/2005 | CN1222539C Human receptor proteins, related reagents and methods |
| 10/12/2005 | CN1222538C Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 10/12/2005 | CN1222536C Prevention and treatment of hepatocellular cancer |